About
Field of Business
Pipeline
History
Location
Technology
Nanohybrid-based transfection reagent
Exosome hybrid
Patents & Certifications
Products
Transfection Reagent
Solfect™
Solfect-i™
Solfect-m™
Solfect-v™
Reference
Support
FAQ
Reviews
Inquiry
Announcement
Sample request
/ inquiry
KO
About
Field of Business
Pipeline
History
Location
Technology
Nanohybrid-based transfection reagent
Exosome hybrid
Patents & Certifications
Products
Transfection Reagent
- Solfect™
- Solfect-i™
- Solfect-m™
- Solfect-v™
Reference
Support
FAQ
Reviews
Inquiry
Announcement
Announcement
About
Biosolyx Co., Ltd. is a research-oriented company that creates value for our customers
History
2022
Awarded as a Daegu-Gyeongbuk High-Tech Venture Industry Awards Venture Company
MOU on the development of vaccines to prevent animal diseases signed
Joint research agreement for the development of pulmonary fibrosis treatment signed
Excellent technology evaluation company (TCB) T-3 Level Certification
KRW 300 million in seed investment attracted
2021
Production Technology Research Institute product certification
Gene delivery material patent registration
2020
Venture Business Certification
Selected as a TIPS project for start-up growth technology development project
Established affiliated research institute
2019
Biosolyx Co., Ltd. Establishment
Attracted KRW 150 million in seed investment